AiPharma was granted permission to supply a 200mg celecoxib under the brand name of Vobrax. Vobrax is indicated for the treatment of:
- Rheumatoid arthritis
- Osteoarthritis
- Short-term (acute) pain
What is Celecoxib?
Celecoxib belongs to a class of medicines known as cyclooxygenase-2 (COX-2) inhibitors, a subgroup of non-steroidal anti-inflammatory drugs (NSAIDs). Unlike traditional NSAIDs such as aspirin or ibuprofen, COX-2 inhibitors are designed to be gentler on the stomach, reducing the risk of gastric irritation and ulcers.
Vobrax is part of AiPharma’s portfolio reflecting our commitment to delivering innovative, high-quality, and affordable treatment options for patients living with chronic and acute conditions
